184 Grants (Page 3 of 8)
2013
Regulating hematopoietic stem cells and hematopoiesis for clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 3P30DK090948-04S1), $32,210USD, 09/30/2010 -- 06/30/2015
 
Regulating hematopoietic stem cells and hematopoiesis for clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5P30DK090948-04), $707,543USD, 09/30/2010 -- 06/30/2015
 
Regulation of Hematopoietic Cell Production
Broxmeyer, Hal E
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5T32DK007519-28), $485,484USD, 07/01/1985 -- 06/30/2016
2012
Basic Science Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL007910-14), $405,060USD, 07/01/1999 -- 08/31/2014
 
Cytokine Enhancement of Myeloid Progenitor Cell Survival
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL067384-10), $377,870USD, 06/15/2001 -- 06/30/2015
 
Enhancing Engraftment of Cord Blood by CD26 Inhibition
Broxmeyer, Hal E and Farag, Sherif S
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL112669-01), $760,603USD, 03/01/2012 -- 02/28/2017
 
Mechanisms of Synergistic Regulation of Stem/Progenitors
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL056416-15), $381,150USD, 04/01/1996 -- 12/31/2013
 
Regulating hematopoietic stem cells and hematopoiesis for clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5P30DK090948-03), $750,151USD, 09/30/2010 -- 06/30/2015
 
Regulation of Hematopoietic Cell Production
Broxmeyer, Hal E
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5T32DK007519-27), $400,321USD, 07/01/1985 -- 06/30/2016
2011
Basic Science Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL007910-13), $309,442USD, 07/01/1999 -- 08/31/2014
 
Cytokine Enhancement of Myeloid Progenitor Cell Survival
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2R01HL067384-09A1), $385,000USD, 06/15/2001 -- 06/30/2015
 
Mechanisms of Synergistic Regulation of Stem/Progenitors
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL056416-14), $385,000USD, 04/01/1996 -- 12/31/2013
 
Regulating hematopoietic stem cells and hematopoiesis for clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5P30DK090948-02), $717,351USD, 09/30/2010 -- 06/30/2015
 
Regulating hematopoietic stem cells and hematopoiesis for clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 3P30DK090948-02S1), $32,800USD, 09/30/2010 -- 06/30/2015
 
Regulation of Hematopoietic Cell Production
Broxmeyer, Hal E
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 2T32DK007519-26), $484,718USD, 07/01/1985 -- 06/30/2016
2010
Basic Science Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5T32HL007910-12), $331,189USD, 07/01/1999 -- 08/31/2014
 
Mechanisms of Synergistic Regulation of Stem/Progenitors
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2R01HL056416-13A1), $385,000USD, 04/01/1996 -- 12/31/2013
 
Regulating hematopoietic stem cells and hematopoiesis for clinical efficacy
Broxmeyer, Hal E and Srour, Edward F
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 1P30DK090948-01), $739,912USD, 09/30/2010 -- 06/30/2015
2009
Basic Science Studies on Gene Therapy of Blood Diseases
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2T32HL007910-11A1), $428,104USD, 07/01/1999 -- 08/31/2014
 
Bridges to the Doctorate at IU School of Medicine
Broxmeyer, Hal E
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 2R25GM067592-07), $295,887USD, 06/01/2003 -- 08/31/2014
 
Chemokines, Gene Transfer, and Engrafting Stem Cells
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5P01HL053586-15), $451,114USD, 2009
 
Cytokine Enhancement of Myeloid Progenitor Cell Survival
Broxmeyer, Hal E
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL067384-08), $366,553USD, 06/01/2001 -- 05/31/2011
 
Indiana University Initiative for Maximizing Graduate Student Diversity
Broxmeyer, Hal E
National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (ID: 5R25GM079657-03), $365,259USD, 03/15/2007 -- 02/28/2011
 
Interactions between different stem/progenitor cells in tissue repair and aging
Broxmeyer, Hal E⋅March, Keith L and Yoder, Mervin C
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R03HL096381-01), $38,500USD, 12/01/2008 -- 05/31/2009
 
REGULATION OF HEMATOPOIETIC CELL PRODUCTION
Broxmeyer, Hal E
National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (ID: 5T32DK007519-25), $350,532USD, 07/01/1985 -- 06/30/2011